Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Revenue

Keros Therapeutics had revenue of $15.01M in the twelve months ending June 30, 2026, down -93.55% year-over-year. In the year 2025, Keros Therapeutics had annual revenue of $244.06M with 6,774.96% growth. That makes Keros Therapeutics the 35,417th largest company in the world by revenue and 4,667th in the United States.

• Revenue (ttm): $15.01M
• Revenue Growth: -93.55%
• P/S Ratio: 14.90
• Revenue / Employee: $163,196
• Employees: 92
• Market Cap: 225.63M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	244.06M	240.51M	6,774.96%
Dec 31, 2024	3.55M	3.40M	2,250.99%
Dec 31, 2023	151.00K	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	20.10M	-	-
Dec 31, 2020	-	-	-
Dec 31, 2019	10.00M	-	-
Dec 31, 2018	10.00M	-	-

Data Source: Fiscal.ai Last updated: Aug 3, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 25, 2026

Data Sources Report a data error